Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL28255974 | 0.98 | THRB (0.52) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL27375881 | 0.89 | THRB (0.44) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL1108012 | 0.88 | TSHR (0.58) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL8965485 | 0.87 | THRB (0.53) | THRBTSHRALDH1A1POLBAPEX1 | |
| Fluoride SCHEMBL28254640 | 0.86 | TSHR (0.56) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL3688925 | 0.85 | THRB (0.52) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL22686158 | 0.85 | THRB (0.52) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL18051644 | 0.85 | THRB (0.52) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL24604172 | 0.85 | THRB (0.41) | THRBTSHRALDH1A1 | |
| SCHEMBL26002227 | 0.84 | THRB (0.55) | THRBTSHRALDH1A1POLBAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 343 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713399-A1 | WATERBORNE ACRYLIC COATING COMPOSITION | SWIMC LLC (US) | 2026-03-25 | — | — | EP | claimed |
| EP-4709768-A1 | BIOBASED LATEX HAVING INCREASED C14 CONTENT, METHODS OF MAKING AND METHODS OF USING | SWIMC LLC (US) | 2026-03-18 | — | — | EP | claimed |
| US-20260062558-A1 | COATINGS COMPRISING SILICATE | SWIMC LLC (US) | 2026-03-05 | — | — | US | claimed |
| EP-4688968-A1 | A WATERBORNE SINGLE STAGE ACRYLIC LATEX WITH SUBSTANTIALLY NO COALESCING AGENTS AND COATINGS FORMED THEREFROM | SWIMC LLC (US) | 2026-02-11 | — | — | EP | claimed |
| WO-2025024325-A2 | ALL-ACRYLIC TRIBLOCK AND TETRABLOCK COPOLYMERS HAVING A LACTAM MOIETY AND APPLICATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2025-01-30 | — | — | WO | claimed |
| WO-2024242911-A1 | WATERBORNE ACRYLIC COATING COMPOSITION | SWIMC LLC (US) | 2024-11-28 | — | — | WO | claimed |
| US-20240384127-A1 | WATERBORNE ACRYLIC RESIN CONTAINING INORGANIC CROSSLINKING AGENT, LATEX CONTAINING THE SAME AND COATINGS FORMED FROM THE SAME | SWIMC LLC | 2024-11-21 | — | — | US | claimed |
| US-20240376338-A1 | BIOBASED LATEX HAVING INCREASED C14 CONTENT, METHODS OF MAKING AND METHODS OF USING | SWIMC LLC (US) | 2024-11-14 | — | — | US | claimed |
| WO-2024233602-A1 | BIOBASED LATEX HAVING INCREASED C14 CONTENT, METHODS OF MAKING AND METHODS OF USING | SWIMC LLC (US) | 2024-11-14 | — | — | WO | claimed |
| WO-2024211116-A1 | A WATERBORNE SINGLE STAGE ACRYLIC LATEX WITH SUBSTANTIALLY NO COALESCING AGENTS AND COATINGS FORMED THEREFROM | SWIMC LLC (US) | 2024-10-10 | — | — | WO | claimed |
| EP-3417008-A1 | POLYMER COMPOSITION COMPRISING A (METH)ACRYLIC POLYMER HAVING GOOD OPTICAL PROPERTIES AND HEAT RESISTANCE | SABIC Global Technologies B.V. (NL) | 2018-12-26 | — | — | EP | claimed |
| WO-2018028883-A1 | POLYMER COMPOSITION COMPRISING A (METH)ACRYLIC POLYMER | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2018-02-15 | — | — | WO | claimed |
| WO-2017174377-A1 | POLYMER COMPOSITION COMPRISING A (METH)ACRYLIC POLYMER AND POLYACRYLONITRILE | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2017-10-12 | — | — | WO | claimed |
| WO-2017162393-A1 | POLYMER COMPOSITION COMPRISING A (METH)ACRYLIC POLYMER HAVING GOOD OPTICAL PROPERTIES AND HEAT RESISTANCE | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2017-09-28 | — | — | WO | claimed |
| US-9580558-B2 | Polymers containing siloxane monomers | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2017-02-28 | — | — | US | claimed |
| CN-105247002-A | Pressure sensitive adhesive composition | MOMENTIVE SPECIALTY CHEM INC | 2016-01-13 | — | — | CN | claimed |
| US-8648160-B2 | Optical semiconductor sealing material | IDEMITSU KOSAN CO., LTD. (JP) | 2014-02-11 | — | — | US | claimed |
| US-7875285-B1 | n acrylic ester polymer including a drug having anovercoating of a different acrylic ester polymer having a glass transition temperature of 35-50 degrees C. to control elution of the drug; temperature change morphology of drug polymer to change and increase release; thrombolytic agents; restenosis | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2011-01-25 | — | — | US | claimed |
| US-7494665-B1 | Polymers containing siloxane monomers | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2009-02-24 | — | — | US | claimed |
| US-20080262606-A1 | POLYMERS CONTAINING SILOXANE MONOMERS | ABBOTT CARDIOVASCULAR SYSTEMS INC. | 2008-10-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062558-A1 | COATINGS COMPRISING SILICATE | ALG3, MACF1, ILK | THRB 3176/4885TSHR 4488/4885ALDH1A1 2378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.